secwatch.observer — SEC 8-K summary
======================================

Issuer:     GoHealth, Inc. (GOCO)
CIK:        0001808220
Form:       8-K
Filed at:   2023-08-10T23:59:59+00:00
Accession:  0001808220-23-000087
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GoHealth Q2 revenue falls 10% to $142.8M, but Adj EBITDA positive; rejects $20/share bid
--------------------------------------------------------------------------------

- Q2 net revenue $142.8M, down 10% YoY from $158.7M; net loss improved to $70.2M from $113.8M.
- Adjusted EBITDA Q2 positive $0.8M vs negative $31.7M prior year; YTD Adj EBITDA $29.6M.
- Submissions grew 5% to 162,837; company exited non-Encompass BPO services in Q2.
- Special Committee rejected $20/share unsolicited buyout proposal from two largest stockholders; says proposal undervalues company.
- Updated FY2023 guidance: net revenue $800-850M, Adj EBITDA $120-140M, cash flow $75-115M, raising lower bounds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/0001808220-23-000087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1808220/000180822023000087/goco-20230810.htm
  HTML page:      https://secwatch.observer/filing/0001808220-23-000087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer